Psychiatric Digital Biomarkers Market Size, Share, Forecast Report 2026 to 2035
What is Psychiatric Digital Biomarkers Market Size?
The Psychiatric Digital Biomarkers Market Size is valued at USD 708.39 Mn in 2025 and is predicted to reach USD 6,467.01 Mn by the year 2035 at an 25.4 % CAGR during the forecast period for 2026 to 2035.
Psychiatric Digital Biomarkers Market, Share & Trends Analysis Report, By Type (Wearable, Mobile based Applications, Sensors), Clinical Practice (Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers), End Use, By Region, and Segment Forecasts, 2026 to 2035.
Psychiatric Digital Biomarkers Market Key Takeaways:
|
The global market for psychiatric digital biomarkers focuses on the creation, application, and utilization of digital technologies designed to measure and analyze physiological and behavioral data for diagnosing, tracking, and treating mental illnesses. These technologies aim to identify potential mental health issues before they become severe, providing a quantitative approach to mental health assessment compared to traditional subjective methods. By tracking mental health changes over time, these biomarkers enable timely interventions and facilitate the tailoring of treatment plans based on individual biomarker patterns.
Large-scale user-generated data gathering and utilization as "digital biomarkers" are made possible by the ubiquity of digital devices like wearables and smartphones. These resources might also encourage more mental health patients to take part in research, which would lead to the creation of findings that have personal significance for the patients. In 2022, Frontiers published digital biomarkers in psychiatric research of data protection qualifications in a complex ecosystem, showing the rapid advancement of psychiatric digital biomarkers has brought with it a complex landscape of legal and regulatory considerations. Given the sensitive nature of mental health data, and the potential implications of these technologies, robust frameworks are essential.
Competitive Landscape
Some of the Major Key Players in the Psychiatric Digital Biomarkers Market are
- Koneksa
- Biogen Inc.
- BioSensics
- Empatica Inc.
- Vivo Sense
- IXICO plc
- Huma
- kintsugi health
- Sonde Health, Inc.
- Clario
- iMediSync
- BEATS Medical
- Other Prominent Players
Market Segmentation:
The Psychiatric Digital Biomarkers Market is segmented based on the type, clinical practice, and end-use. Based on the type, the market is segmented into wearable, mobile-based applications, sensors, and others. Based on the clinical practice, the market is segmented into diagnostic psychiatric digital biomarkers, monitoring psychiatric digital biomarkers, predictive and prognostic psychiatric digital biomarkers, others. Based on the end use, the market is segmented into healthcare companies, healthcare providers, payers, and others.
The Wearable Devices Segment is Expected to have the highest growth rate during the forecast period
Based on the type, the market is segmented into wearable, mobile-based applications, sensors, and others. Among these, the wearable devices segment is expected to have the highest growth rate during the forecast period. These devices are widely used due to their ability to continuously collect physiological data, such as heart rate, sleep patterns, and activity levels, which are crucial for monitoring mental health conditions. This ongoing data collection offers insightful information on a patient's mental health condition, including changes in mood, sleep habits, and degree of physical activity. Wearables are dominating the market because of their attractiveness as a tracking and management tool for psychiatric illnesses due to these characteristics.
The Monitoring Psychiatric Digital Biomarkers Segment Dominates the Market
Based on the clinical practice, the market is segmented into diagnostic psychiatric digital biomarkers, monitoring psychiatric digital biomarkers, predictive and prognostic psychiatric digital biomarkers, others. Among these, the monitoring psychiatric digital biomarkers segment dominates the market. This segment leads the market due to the growing demand for continuous, real-time monitoring of mental health conditions. Monitoring biomarkers, such as physiological data from wearables or behavioral data from mobile applications, helps track the progression of mental health conditions and assess treatment effectiveness.
North America Have the Largest Market Share During Forecast Period
Mental health issues are prevalent in North America, driving demand for innovative solutions for diagnosis, monitoring, and treatment. This high prevalence encourages investment in and development of psychiatric digital biomarkers. North America is a hub for technological innovation, with numerous tech companies and startups focusing on digital health solutions. This innovation drives the development and commercialization of new psychiatric digital biomarkers.
Recent Developments:
- In March 2024, Biogen announced the initial results from a trial named RESPOND, which assessed SPINRAZA in babies and toddlers with specific requirements following gene therapy. The majority of patients showed improved motor performance and a decrease in markers of neurodegeneration.
- In Feb 2024, Empatica, declared the official launch of EpiMonitor, our most recent development in wearable epilepsy monitoring technology, giving families and individuals with epilepsy even more peace of mind. EpiMonitor is the only wearable seizure detection system that is approved by the FDA and may be purchased in the United States. It is approved for usage in adult and pediatric populations aged six and above.
Psychiatric Digital Biomarkers Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 708.39 Mn |
| Revenue Forecast In 2035 | USD 6,467.01 Mn |
| Growth Rate CAGR | CAGR of 25.4 % from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, Clinical Practice, End use |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
| Competitive Landscape | Koneksa, Biogen Inc., BioSensics, Empatica Inc., Vivo Sense, IXICO plc, Huma, kintsugi health Sonde Health, Inc., Clario, icometrix, iMediSync, BEATS Medical |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Psychiatric Digital Biomarkers Market
Global Psychiatric Digital Biomarkers Market - By Type
- Wearable
- Mobile based Applications
- Sensors
- Others
Global Psychiatric Digital Biomarkers Market - Clinical Practice
- Diagnostic Psychiatric Digital Biomarkers
- Monitoring Psychiatric Digital Biomarkers
- Predictive and Prognostic Psychiatric Digital Biomarkers
- Other's
Global Psychiatric Digital Biomarkers Market – End Use
- Healthcare companies
- Healthcare Providers
- Payers
- Others
Global Psychiatric Digital Biomarkers Market – By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Psychiatric Digital Biomarkers Market Size is valued at USD 708.39 Mn in 2025 and is predicted to reach USD 6,467.01 Mn by the year 2035.
The Psychiatric Digital Biomarkers Market is expected to grow at an 25.4% CAGR during the forecast period for 2026-2035.
Koneksa, Biogen Inc., BioSensics, Empatica Inc., Vivo Sense, IXICO plc, Huma, kintsugi health Sonde Health, Inc., Clario, icometrix, iMediSync, BEATS
Psychiatric Digital Biomarkers Market is segmented based on the type, clinical practice, and end-use.
North American region is leading the Psychiatric Digital Biomarkers Market.